North Star Investment Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

North Star Investment Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,000	Closed	-$4K	–	1044
2019 Q1	$4K	Hold	1,000	–	–	﹤0.01%	965
2018 Q4	$6K	Hold	1,000	–	–	﹤0.01%	896
2018 Q3	$6K	Hold	1,000	–	–	﹤0.01%	921
2018 Q2	$4K	Hold	1,000	–	–	﹤0.01%	994
2018 Q1	$4K	Hold	1,000	–	–	﹤0.01%	977
2017 Q4	$5K	Hold	1,000	–	–	﹤0.01%	934
2017 Q3	$6K	Hold	1,000	–	–	﹤0.01%	928
2017 Q2	$7K	Hold	1,000	–	–	﹤0.01%	891
2017 Q1	$5K	Hold	1,000	–	–	﹤0.01%	899
2016 Q4	$7K	Buy	+1,000	New	+$8.09K	﹤0.01%	803

Other funds holding PETX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

North Star Investment Management's PETX Position: Q2 2019 in Review

North Star Investment Management sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2019, closing a stake of 1,000 shares — an estimated $4K sold.

North Star Investment Management first reported a position in PETX in Q4 2016 and held it in 10 quarters. The position peaked at $7K in Q2 2017. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.

North Star Investment Management reported no remaining Aratana Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
North Star Investment Management sold 1,000 Aratana Therapeutics, Inc. shares in Q2 2019, an estimated $4K.
North Star Investment Management first reported a position in Aratana Therapeutics, Inc. in Q4 2016 and held it in 10 quarters.
North Star Investment Management's Aratana Therapeutics, Inc. position peaked at $7K in Q2 2017.
103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.

Based on North Star Investment Management's 13F filing for Q2 2019, filed 15 Jul 2019.